Functional, Patient-Centered and Bone Remodeling Outcomes in Two Narrow-Diameter Implant Retained Mandibular Overdenture Wearers After 5 Years of Follow-Up: A Prospective Case Series

两例窄直径种植体固位式下颌覆盖义齿佩戴者5年随访后的功能性、以患者为中心的治疗效果及骨改建结果:一项前瞻性病例系列研究

阅读:1

Abstract

OBJECTIVES: This prospective longitudinal case series investigated changes in functional, radiographic, and patient-centered outcomes in users of two narrow-diameter implant-retained mandibular overdentures (IMO) over a 5-year follow-up. MATERIALS AND METHODS: Twenty-four patients from a previous 3-year study (8 man, 16 women, 71.58 ± 7.03 years, mean mandibular edentulism duration 23.9 ± 14.4 years) were invited for a 5-year follow-up evaluation of radiographic and functional parameters. Masticatory function (MF) was assessed using the Swallowing Threshold Test (ST), with X50 and B cut-off values indicating satisfactory performance. Oral health-related quality of life (OHRQoL) was evaluated using the OHIP-Edent questionnaire. The Posterior Mandibular Area Index (PAI) was analyzed using digital panoramic radiographs. Data was analyzed using multilevel mixed-effects linear regression. RESULTS: Twenty participants completed the 5-year follow-up evaluation. ST_X50 (4.00-3.70; p ≤ 0.01; 95% CI: 0.47-1.82) reached a significant reduction along with an increased number of masticatory cycles (59.33-65.60; p ≤ 0.01; 95% CI: 0.32-1.11) between years. The number of IMO wearers presenting satisfactory mastication increased but persisted as unsatisfactory in nine participants by year 5. Declines in the Functional Limitation and Physical Disability domains of OHRQoL were noted, with unsatisfactory mastication correlating with higher pain (coef: 2.5; p: 0.03; 95% CI: 0.25-4.74) and psychological disability scores (coef: 0.94; p ≤ 0.01; 95% CI: 0.19-1.68). PAI increased significantly (1.13-1.68; p ≤ 0.01; 95% CI: 0.24-0.56), indicating ongoing bone remodeling. CONCLUSIONS: Although MF and bone parameters improved over 5 years, persistent unsatisfactory mastication continued to negatively affect quality of life. These findings underscore the interdependence between functional and patient-centered outcomes in IMO users. TRIAL REGISTRATION: The Brazilian Registry of Clinical Trials (ReBEC), Trial identification: UTN code: U1111-1259-4127.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。